Sea Crest Wealth Management, LLC Novo Nordisk A S Transaction History

Sea Crest Wealth Management, LLC

$916 Million
Q4 2024

A detailed history of Sea Crest Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 11,516 shares of NVO stock, worth $956,634. This represents 0.11% of its overall portfolio holdings.

Number of Shares

11,516

Previous 17,463 34.05%

Holding current value

$956,634

Previous $2.08 Million 52.38%

% of portfolio

0.11%

Previous 0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$85.0 - $120.04 $505,495 - $713,877	-5,947 Reduced 34.05%	11,516 $990,000
Q3 2024 Oct 16, 2024	SELL	$119.07 - $145.42 $8,692 - $10,615	-73 Reduced 0.42%	17,463 $2.08 Million
Q2 2024 Jul 19, 2024	BUY	$122.71 - $146.91 $58,287 - $69,782	475 Added 2.78%	17,536 $2.5 Million
Q1 2024 Apr 18, 2024	SELL	$102.11 - $135.92 $10,823 - $14,407	-106 Reduced 0.62%	17,061 $2.19 Million
Q4 2023 Jan 18, 2024	BUY	$87.78 - $105.45 $270,625 - $325,102	3,083 Added 21.89%	17,167 $1.78 Million
Q3 2023 Oct 12, 2023	BUY	$90.94 - $199.54 $778,264 - $1.71 Million	8,558 Added 154.87%	14,084 $1.28 Million
Q2 2023 Jul 14, 2023	BUY	$155.98 - $172.65 $115,581 - $127,933	741 Added 15.49%	5,526 $894,000
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $136,177 - $163,755	1,029 Added 27.4%	4,785 $761,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $79,168 - $104,474	772 Added 25.87%	3,756 $508,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $31,061 - $38,119	326 Added 12.26%	2,984 $297,000
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $1,548 - $1,827	-15 Reduced 0.56%	2,658 $296,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $43,757 - $52,893	470 Added 21.33%	2,673 $297,000
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $3,164 - $3,863	-33 Reduced 1.48%	2,203 $247,000
Q3 2021 Nov 16, 2021	SELL	$84.42 - $106.62 $12,831 - $16,206	-152 Reduced 6.37%	2,236 $215,000
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $161,572 - $202,406	2,388 New	2,388 $200,000
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $173,011 - $226,600	-3,498 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$49.86 - $58.26 $174,410 - $203,793	3,498 New	3,498 $202,000
Q2 2019 Jul 19, 2019	SELL	$46.79 - $52.47 $186,130 - $208,725	-3,978 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$46.36 - $52.63 $5,331 - $6,052	115 Added 2.98%	3,978 $208,000
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $2,866 - $3,260	-69 Reduced 1.75%	3,863 $178,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $23,520 - $25,773	503 Added 14.67%	3,932 $185,000
Q2 2018 Aug 03, 2018	BUY	$44.29 - $50.42 $1,372 - $1,563	31 Added 0.91%	3,429 $158,000
Q1 2018 Apr 20, 2018	BUY	$48.49 - $58.14 $5,333 - $6,395	110 Added 3.35%	3,398 $167,000
Q4 2017 Feb 02, 2018	BUY	$47.53 - $53.73 $156,278 - $176,664	3,288	3,288 $176,000

Others Institutions Holding NVO

# of Institutions

1,939

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $188B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.

Account

Sea Crest Wealth Management, LLC Novo Nordisk A S Transaction History